{"id":448,"date":"2023-03-17T16:15:01","date_gmt":"2023-03-17T16:15:01","guid":{"rendered":"https:\/\/arcaid-h2020.eu\/?page_id=448"},"modified":"2023-03-17T16:35:31","modified_gmt":"2023-03-17T16:35:31","slug":"full-project-description-esr4","status":"publish","type":"page","link":"https:\/\/arcaid-h2020.eu\/?page_id=448","title":{"rendered":"Full Project Description ESR 4"},"content":{"rendered":"<p><span style=\"color: #000000; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\"><b>ESR 4:<\/b> <\/span><span style=\"color: #000000; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\"><b>Clonal isotyping of the B cell response in autoimmunity &#8211; <span style=\"color: #ff0000;\">POSITION FILLED<\/span><\/b><\/span><\/p>\n<p><span style=\"color: #000000; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\">PhD research<\/span><\/p>\n<p><span style=\"text-decoration: underline; color: #0000ff;\"><span style=\"font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;\">Host:<\/span><\/span><\/p>\n<p><span style=\"color: #000000; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\"><b><span lang=\"FR\">Prof. dr. N. de Vries (Niek)<\/span><\/b><\/span><\/p>\n<p><span style=\"color: #000000;\">&nbsp;<span lang=\"FR\" style=\"font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\">Dept Clinical Immunology &amp; Rheumatology<\/span><\/span><\/p>\n<p style=\"text-align: justify; text-justify: inter-ideograph;\"><span lang=\"EN-US\" style=\"color: #000000; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\">Amsterdam Rheumatology and immunology Center (ARC)<\/span><\/p>\n<p>&nbsp;<span lang=\"EN-US\" style=\"color: black; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\">Rheumatology &amp; Clinical Immunology &amp; Experimental Immunology<\/span><\/p>\n<p><span lang=\"EN-US\" style=\"color: black; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\">Location AMC | D3-220 |&nbsp;Meibergdreef 9 1105 AZ Amsterdam<\/span><\/p>\n<p><span style=\"font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\"><span lang=\"EN-US\" style=\"color: black;\">T: +31205667765&nbsp; |&nbsp; E: <\/span><span lang=\"FR\" style=\"color: #0000ff;\"><a style=\"color: #0000ff;\">n.devries1@amsterdamumc.nl<\/a><\/span> <\/span><\/p>\n<p><span lang=\"FR\" style=\"color: #0000ff; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\"> https:\/\/www.amc.nl\/web\/research-75\/person-1\/prof.-dr.-n.-de-vries-md-phd.htm<\/span><i><\/i><\/p>\n<p><span style=\"color: #000000; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\"><span style=\"text-decoration: underline; color: #0000ff;\">Duration: <\/span>48 months<\/span><\/p>\n<p><span style=\"text-decoration: underline;\"><span style=\"color: #0000ff; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt; text-decoration: underline;\">Background<\/span><\/span><\/p>\n<p><span style=\"color: #000000; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\">Many HLA class II associated autoimmune diseases are characterized by the presence of disease-specific antibodies, e.g. rheumatoid arthritis and vasculitis.<\/span><\/p>\n<p><span style=\"color: #000000; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\">These antibody responses come in different isotypes and subtypes, each expressed at selected locations in the body, each having different functional characteristics, potentially having different roles in immune memory. For instance, the IgG4 antibodies have low affinity for complement and the Fc receptor, and have been implied in regulation of the humoral immune response in many instances, e.g. in IgG4-related disease. However, in the skin disease pemphigus the antibodies are thought to be pathogenic, but highly responsive to anti-B cell therapy. We published that high IgG4-responses correlate with disease activity in vasculitis, and showed that their presence differentiates active vasculitis from its disease mimics.<\/span><\/p>\n<p><span style=\"color: #000000; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\">Recently it has been reported that clones might follow specific isotype switches during their development. These development paths might help us to identify the tissue origins of a response, functionally characterize ongoing adaptive responses, differentiate subtypes of disease, and predict therapeutic responses, e.g. to B-cell directed therapies. We recently developed novel B-cell repertoire sequencing technologies that can perform highly accurate quantitative assessment of clonal BCR responses based on the incorporation of unique molecular identifiers (UMI) before large scale amplification. Using this technology we aim to unravel the isotype history and characteristics of the autoantibody response in different diseases, and its relevance for response to B-cell directed therapies.<\/span><\/p>\n<p><span style=\"text-decoration: underline; color: #0000ff;\"><span style=\"font-family: tahoma, arial, helvetica, sans-serif; font-size: 12pt;\">Approach&nbsp;<\/span><\/span><\/p>\n<p><span style=\"color: black; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\">The PhD candidate will get acquainted with existing high-throughput sequencing approaches of the B cell and T cell receptor genes and existing data analysis methods to study lymphocyte repertoires. Samples from patients with different autoimmune disease are available in the biobank locally and from collaborating partners. The technologies will be used to analyse the isotype history of disease associated clones in different diseases, and study the effect of therapy, including B-cell directed therapies.<\/span><\/p>\n<p><span style=\"text-decoration: underline;\"><span lang=\"EN-US\" style=\"color: #0000ff; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt; text-decoration: underline;\">Our research team<\/span><\/span><\/p>\n<p style=\"margin: 0.65pt -1.15pt 0pt 0cm; text-align: justify; text-justify: inter-ideograph;\"><span style=\"color: black; font-family: tahoma,arial,helvetica,sans-serif; font-size: 12pt;\"><span lang=\"EN-US\">Our team aims to better understand the interactions between HLA-presenting APCs, T-cells and B cells that define specificity in, and regulate the disease-associated adaptive immune responses in autoimmune disease. To this end we study <\/span><span lang=\"EN-US\">unique biobanked and freshly acquired materials from blood, human lymph nodes, bone marrow and synovial tissue obtained during the pre-clinical and earliest phases of autoimmune disease, e.g. in rheumatoid arthritis and vasculitis. The goal is to improve clinical management of these diseases by developing novel biomarkers and identification of new targets for novel therapies.<\/span><span lang=\"EN-US\"> Our <\/span><span lang=\"EN-US\">team currently consists of 5 PhD students, 1 postdoc and 2 research technicians. <\/span><span lang=\"EN-US\">For more information see <span style=\"color: #0000ff;\">https:\/\/www.amc.nl\/web\/research-75\/person-1\/prof.-dr.-n.-de-vries-md-phd.htm<\/span>. <\/span><\/span><\/p>\n<p style=\"margin: 0.65pt -1.15pt 0pt 0cm; text-align: justify; text-justify: inter-ideograph;\"><span style=\"color: black; font-size: 12pt;\"><span style=\"font-family: tahoma,arial,helvetica,sans-serif;\"><span lang=\"EN-US\">The project is a close collaboration with prof. dr. Antoine van Kampen of the The Bioinformatics Laboratory. <\/span><span lang=\"EN-US\">The team is embedded within the recently established Amsterdam Rheumatology and immunology Center (ARC) and the Amsterdam Infection &amp; Immunity Institute (AI&amp;II).<\/span><\/span><span lang=\"EN-US\"><span style=\"font-family: tahoma,arial,helvetica,sans-serif;\"> We are involved in several national and international research projects, allowing excellent possibilities for collaborations with other research groups in academia as well as industry.<\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ESR 4: Clonal isotyping of the B cell response in autoimmunity &#8211; POSITION FILLED PhD research Host: Prof. dr. N.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-448","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/arcaid-h2020.eu\/index.php?rest_route=\/wp\/v2\/pages\/448","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arcaid-h2020.eu\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/arcaid-h2020.eu\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/arcaid-h2020.eu\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/arcaid-h2020.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=448"}],"version-history":[{"count":2,"href":"https:\/\/arcaid-h2020.eu\/index.php?rest_route=\/wp\/v2\/pages\/448\/revisions"}],"predecessor-version":[{"id":485,"href":"https:\/\/arcaid-h2020.eu\/index.php?rest_route=\/wp\/v2\/pages\/448\/revisions\/485"}],"wp:attachment":[{"href":"https:\/\/arcaid-h2020.eu\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}